STK11 and metabolic disease: These findings offer novel insights into the underlying mechanisms by which OLE-JGF affects the LKB1-PGC-1α signaling pathway involved in modulating lipid metabolism, as well as supporting the potential use of OLE-JGF as a supplement for minimizing the risks of various metabolic diseases.